Dr. Rosen describes follicular lymphoma and shares how often it occurs.
Follicular lymphoma is the second most common type of non-Hodgkin’s lymphoma. It’s usually indolent in its progression, which means slowly progressive. We currently cannot cure follicular lymphomas. However, we have therapies that can control the disease for many years. In some instances, we’ll initially observe a patient and not initiate treatment. When we elect to initiate therapy, it may involve combination chemotherapy, which means multiple drugs, or it may involve antibody therapy alone. These are proteins that target the B-cell lymphoma, or at times a combination of chemotherapy and antibody therapy.
About Dr. Steven Rosen, M.D., F.A.C.P:
Steven Rosen, M.D., F.A.C.P., is Genevieve Teuton Professor of Medicine, at the Feinberg School of Medicine, Northwestern University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Director of Cancer Programs at Northwestern Memorial Hospital. Following his graduation with distinction from Northwestern University Medical School's Six-Year Honors Program in 1976, Dr. Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr. Rosen's laboratory research focuses on experimental therapeutics and hematologic malignancies.